Chapter 2
Immune Mechanisms in Pediatric Cardiovascular Disease
Wendy A. Luce,
Mandar S. Joshi,
Timothy M. Hoffman,
Timothy F. Feltes,
John Anthony Bauer,
Wendy A. Luce
Search for more papers by this authorMandar S. Joshi
Search for more papers by this authorTimothy M. Hoffman
Search for more papers by this authorTimothy F. Feltes
Search for more papers by this authorJohn Anthony Bauer
Search for more papers by this authorWendy A. Luce,
Mandar S. Joshi,
Timothy M. Hoffman,
Timothy F. Feltes,
John Anthony Bauer,
Wendy A. Luce
Search for more papers by this authorMandar S. Joshi
Search for more papers by this authorTimothy M. Hoffman
Search for more papers by this authorTimothy F. Feltes
Search for more papers by this authorJohn Anthony Bauer
Search for more papers by this authorBook Editor(s):Ronald Ross Watson,
Douglas F. Larson,
Ronald Ross Watson
Department of Nutritional Sciences, The University of Arizona; and Sarver Heart Center, College of Medicine, The University of Arizona
Division of Health Promotion Sciences, Mel and Enid Zuckerman Arizona College of Public Health, The University of Arizona Tucson, AZ USA
Search for more papers by this authorDouglas F. Larson
Sarver Heart Center College of Medicine The University of Arizona Tucson, AZ USA
Search for more papers by this authorSummary
This chapter contains section titled:
-
Introduction
-
Immune system function in pediatric versus adult populations
-
Defining immune system involvement in pediatric cardiovascular disease
-
Pediatric disease states involving immune mechanisms
-
Therapeutic issues and opportunities
-
References
References
- Lange LG Schreiner G.F. Immune mechanisms of cardiac disease. N Engl J Med April 21, 1994; 330 (16): 1129–35.
- Taqueti VR Mitchell RN Lichtman A.H. Protecting the pump: controlling myocardial inflammatory responses. Annu Rev Physiol 2006; 68: 67–95.
- Barry, W.H. Mechanisms of immune-mediated myocyte injury. Circulation May 1994; 89 (5): 2421–32.
- Groner JA Joshi M Bauer J.A. Pediatric precursors of adult cardiovascular disease: noninvasive assessment of early vascular changes in children and adolescents. Pediatrics October 2006; 118 (4): 1683–91.
- West, L.J. Defining critical windows in the development of the human immune system. Hum Exp Toxicol September–October 2002; 21 (9–10): 499–505.
- Holt PG Jones C.A. The development of the immune system during pregnancy and early life. Allergy August 2000; 55 (8): 688–97.
- Haynes BF Denning SM Singer KH Kurtzberg J. Ontogeny of T-cell precursors: a model for the initial stages of human T-cell development. Immunol Today March 1989; 10 (3): 87–91.
- Hannet I Erkeller-Yuksel F Lydyard P Deneys V DeBruyere M. Developmental and maturational changes in human blood lymphocyte subpopulations. Immunol Today June 1992; 13 (6): 215–8.
- Hulstaert F Hannet I Deneys, V et al. Age-related changes in human blood lymphocyte subpopulations. II: Varying kinetics of percentage and absolute count measurements. Clin Immunol Immunopathol February 1994; 70 (2): 152–8.
- Royo C Touraine JL de Bouteiller O. Ontogeny of T lymphocyte differentiation in the human fetus: acquisition of phenotype and functions. Thymus 1987; 10 (1–2): 57–73.
- Hayward, A.R. The human fetus and newborn: development of the immune response. Birth Defects Orig Artic Ser 1983; 19 (3): 289–94.
- Demeure CE Wu CY Shu, U et al. In vitro maturation of human neonatal CD4 T lymphocytes. II. Cytokines present at priming modulate the development of lymphokine production. J Immunol May 15, 1994; 152 (10): 4775–82.
- Strunk T Temming P Gembruch U Reiss I Bucsky P Schultz C. Differential maturation of the innate immune response in human fetuses. Pediatr Res August 2004; 56 (2): 219–26.
- Molloy EJ O'Neill AJ Grantham J. et al. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor have differential effects on neonatal and adult neutrophil survival and function. Pe-diatr Res June 2005; 57 (6): 806–12.
- Schultz C Rott C Temming P Schlenke P Moller JC Bucsky P. Enhanced interleukin-6 and interleukin-8 synthesis in term and preterm infants. Pediatr Res March 2002; 51 (3): 317–22.
- Schultz C Temming P Bucsky P Gopel W Strunk T Har-tel C. Immature anti-inflammatory response in neonates. Clin Exp Immunol January 2004; 135 (1): 130–6.
- Dembinski J Behrendt D Martini R Heep A Bartmann P. Modulation of pro- and anti-inflammatory cytokine 18 production in very preterm infants. Cytokine February 21, 2003; 21 (4): 200–6.
- Carr, R. Neutrophil production and function in newborn infants. Br J Haematol July 2000; 110 (1): 18–28.
- Gessler P Luders R Konig S Haas N Lasch P Kachel, W. Neonatal neutropenia in low birthweight premature infants. Am J Perinatol January 1995; 12 (1): 34–8.
- Gladstone IM Ehrenkranz RA Edberg SC Baltimore R.S. A ten-year review of neonatal sepsis and comparison with the previous fifty-year experience. Pediatr Infect Dis J November 1990; 9 (11): 819–25.
- Wilson, C.B. Immunologic basis for increased susceptibility of the neonate to infection. J Pediatr January 1986; 108 (1): 1–12.
- Baughman, K.L. Diagnosis of myocarditis: death of Dallas criteria. Circulation January 31, 2006; 113 (4): 593–5.
- Aretz, H.T. Myocarditis: the Dallas criteria. Hum Pathol June 1987; 18 (6): 619–24.
- Aretz HT Billingham ME Edwards W. et al. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol January 1987; 1 (1): 3–14.
- Chaves AA Baliga RS Mihm M. et al. Bacterial lipopolysaccharide enhances cardiac dysfunction but not retroviral replication in murine AIDS: roles of macrophage infiltration and toll-like receptor 4 expression. Am J Pathol March 2006; 168 (3): 727–35.
- Chaves AA Mihm MJ Basuray A Baliga R Ayers LW Bauer J.A. HIV/AIDS-related cardiovascular disease. Car-diovasc Toxicol 2004; 4 (3): 229–42.
- Chaves AA Mihm MJ Schanbacher B. et al. Cardiomy-opathy in a murine model of AIDS: evidence of reactive nitrogen species and corroboration in human HIV/AIDS cardiac tissues. Cardiovasc Res October 15, 2003; 60 (1): 108–18.
- Newburger JW Takahashi M Gerber M. et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation October 26, 2004; 110 (17): 2747–71.
- Kawasaki, T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquama-tion of the fingers and toes in children. Arerugi March 1967; 16 (3): 178–222.
- Anderson MS Burns J Treadwell TA Pietra BA Glode M.P. Erythrocyte sedimentation rate and C-reactive protein discrepancy and high prevalence of coronary artery abnormalities in Kawasaki disease. Pediatr Infect Dis J July 2001; 20 (7): 698–702.
- Burns JC Kushner HI Bastian J. et al. Kawasaki disease: a brief history. Pediatrics August 2000; 106 (2): E27.
- Kato H Sugimura T Akagi, T et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation September 15, 1996; 94 (6): 1379–85.
- Naoe S Takahashi K Masuda H Tanaka N. Kawasaki disease. With particular emphasis on arterial lesions. Acta Pathol Jpn November 1991; 41 (11): 785–97.
- Brown TJ Crawford SE Cornwall ML Garcia F Shulman ST Rowley A.H. CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. J Infect Dis October 1, 2001; 184 (7): 940–3.
- Rowley AH Shulman ST Mask C. et al. IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease. J Infect Dis October 2000; 182 (4): 1183–91.
- Burian J Buser P Eriksson U. Myocarditis: the immunol-ogist's view on pathogenesis and treatment. Swiss Med Wkly June 25, 2005; 135 (25–26): 359–64.
- Feldman AM McNamara, D. Myocarditis. N Engl J Med November 9 2000; 343 (19): 1388–98.
- Hjalmarson A Fu M Mobini R. Who are the enemies? Inflammation and autoimmune mechanisms. Eur Heart J Suppl 2002; 4 (suppl G): G27–32.
- Akhtar N Ni J Stromberg D Rosenthal GL Bowles NE Towbin J.A. Tracheal aspirate as a substrate for poly-merase chain reaction detection of viral genome in childhood pneumonia and myocarditis. Circulation April 20, 1999; 99 (15): 2011–8.
- Pauschinger M Doerner A Kuehl, U et al. Enterovi-ral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis. Circulation February 23, 1999; 99 (7): 889–95.
- Cooper LT Jr, Berry GJ Shabetai, R, For Multicenter Giant Cell Myocarditis Study Group Investigators. Idiopathic giant-cell myocarditis—natural history and treatment. N Engl J Med June 26, 1997; 336 (26): 1860–6.
- Mason JW O'Connell JB Herskowitz, A et al. for The Myocarditis Treatment Trial Investigators. A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med August 3, 1995; 333 (5): 269–75.
- Neumann DA Lane JR Allen GS Herskowitz A Rose N.R. Viral myocarditis leading to cardiomyopathy: do cy-tokines contribute to pathogenesis. Clin Immunol Im-munopathol August 1993; 68 (2): 181–90.
- Rose NR Hill S.L. The pathogenesis of postinfectious myocarditis. Clin Immunol Immunopathol September 1996; 80 (3, pt 2): S92–9.
- Frustaci A Chimenti C Calabrese F Pieroni M Thiene G Maseri A. Immunosuppressive therapyfor activelympho-cytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation February 18, 2003; 107 (6): 857–63.
- Drucker NA Colan SD Lewis A. et al. Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation January 1994; 89 (1): 252–7.
- Cox GF Sleeper LA Lowe A. et al. Factors associated with establishing a causal diagnosis for children with car-diomyopathy. Pediatrics October 2006; 118 (4): 1519–31.
- Richardson P McKenna W Bristow, M et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation March 1, 1996; 93 (5): 841–2.
- Kawai, C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation March 2, 1999; 99 (8): 1091–100.
- Muir P Nicholson F Tilzey AJ Signy M English TA Banatvala J.E. Chronic relapsing pericarditis and dilated cardiomyopathy: serological evidence of persistent en-terovirus infection. Lancet April 15, 1989; 1 (8642): 804–7.
- Bowles NE Ni J Kearney D. et al. Detection of viruses in myocardial tissues by polymerase chain reaction. Evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol August 6, 2003; 42 (3): 466–72.
- Felix, SB, Staudt A Dorffel, WV et al. Hemodynamiceffects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study. J Am Coll Cardiol May 2000; 35 (6): 1590–8.
- Gullestad L Aass H Fjeld J. et al. Immunomodulat-ing therapy with intravenous immunoglobulin in patients with chronic heart failure. Circulation January 16, 2001; 103 (2): 220–5.
- Muller J Wallukat G Dandel, M et al. Immunoglobulin adsorption in patients with idiopathic dilated cardiomy-opathy. Circulation February 1, 2000; 101 (4): 385–91.
- Albert LJ Inman R.D. Molecular mimicry and autoim-munity. N Engl J Med December 30, 1999; 341 (27): 2068–74.
- Ferrari I Levin MJ Wallukat, G et al. Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta 1-adrenergic receptor. J Exp Med July 1, 1995; 182 (1): 59–65.
- Gerli R Rambotti P Spinozzi, F et al. Immunologic studies of peripheral blood from patients with idiopathic dilated cardiomyopathy. Am Heart J August 1986; 112 (2): 350–5.
- Mott AR Fraser CDJr, Kusnoor A. et al. The effect of short-term prophylactic methylprednisolone on the incidence and severity of postpericardiotomy syndrome in children undergoing cardiac surgery with car-diopulmonarybypass. J Am CollCardiol May 2001; 37 (6): 1700–6.
- Baskett RJ Nanton MA Warren AE Ross D.B. Human leukocyte antigen-DR and ABO mismatch are associated with accelerated homograft valve failure in children: implications for therapeutic interventions. J Thorac Cardio-vasc Surg July 2003; 126 (1): 232–9.
- Shaddy RE Hunter DD Osborn K. et al. Prospective analysis of HLA immunogenicity of cryopreserved valved allografts used in pediatric heart surgery. Circulation September 1, 1996; 94 (5): 1063–7.
- Bechtel JF Muller-Steinhardt M Schmidtke C Brunswik A Stierle U Sievers H.H. Evaluation of the decellularized pulmonary valve homograft (Syner Graft). J Heart Valve Dis November 2003; 12 (6): 734–9; discussion 9–40.
- Cebotari S Lichtenberg A Tudorache, I et al. Clinical application of tissue engineered human heart valves using autologous progenitor cells. Circulation July 4, 2006; 114 (1, suppl): I132–7.
- Sasayama S Matsumori A Kihara Y. New insights into the pathophysiological role for cytokines in heart failure. Cardiovasc Res June 1999; 42 (3): 557–64.
- Aukrust P Ueland T Lien, E et al. Cytokine network in congestive heart failure secondary to ischemic or idio-pathic dilated cardiomyopathy. Am J Cardiol February 1, 1999; 83 (3): 376–82.
- Levine B Kalman J Mayer L Fillit HM Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med July 26, 1990; 323 (4): 236–41.
- Mihm MJ Bauer J.A. Peroxynitrite-induced inhibition and nitration of cardiac myofibrillar creatine kinase. Biochimie October 2002; 84 (10): 1013–9.
- Mihm MJ Coyle CM Schanbacher BL Weinstein DM Bauer J.A. Peroxynitrite induced nitration and inactiva-tion of myofibrillar creatine kinase in experimental heart failure. Cardiovasc Res March 2001; 49 (4): 798–807.
- Mihm MJ Jing L Bauer J.A. Nitrotyrosine causes selective vascular endothelial dysfunction and DNA damage. J Cardiovasc Pharmacol August 2000; 36 (2): 182–7.
- Mihm MJ Schanbacher BL Wallace BL Wallace LJ Uretsky NJ Bauer J.A. Free 3-nitrotyrosine causes stri-atal neurodegeneration in vivo. J Neurosci June 1, 2001; 21 (11): RC149.
- Mihm MJ Wattanapitayakul SK Piao SF Hoyt DG, Bauer J.A. Effects of angiotensin II on vascular endothelial cells: formation of receptor-mediated reactive nitrogen species. Biochem Pharmacol April 1, 2003; 65 (7): 1189–97.
- Mihm MJ Yu F Reiser PJ Bauer J.A. Effects of per-oxynitrite on isolated cardiac trabeculae: selective im-pactonmyofibrillar energetic controllers. Biochimie June 2003; 85 (6): 587–96.
- Vincent JL Sakr Y Sprung C. et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med February 2006; 34 (2): 344–53.
- Carcillo, J.A. Pediatric septic shock and multiple organ failure. Crit Care Clin July 2003; 19 (3): 413–40, viii.
- Kumar A Kumar A Michael, P et al. Human serum from patients with septic shock activates transcription factors STAT1, IRF1, and NF-kappaB and induces apoptosis in human cardiac myocytes. J Biol Chem December 30, 2005; 280 (52): 42619–26.
- Maeder, M, Fehr T Rickli H Ammann P. Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest May 2006; 129 (5): 1349–66.
- von Rosenstiel N von Rosenstiel I Adam D. Management of sepsis and septic shock in infants and children. Paediatr Drugs 2001; 3 (1): 9–27.
- McKiernan CA Lieberman S.A. Circulatory shock in children: an overview. Pediatr Rev December 2005; 26 (12): 451–60.
- Carcillo JA Fields A.I. Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med June 2002; 30 (6): 1365–78.
- Lancel S Joulin O Favory, R et al. Ventricular my-ocyte caspases are directly responsible for endotoxin-induced cardiac dysfunction. Circulation May 24, 2005; 111 (20): 2596–604.
- Lancel S Petillot P Favory, R et al. Expression of apoptosis regulatory factors during myocardial dysfunction in en-dotoxemic rats. Crit Care Med March 2005; 33 (3): 492–6.
- Comstock KL Krown KA Page M. et al. LPS-induced TNF-alpha release from and apoptosis in rat cardiomy-ocytes: obligatory role for CD14 in mediating the LPS response. J Mol Cell Cardiol December 1998; 30 (12): 2761–75.
- Hickson-Bick DL Jones C Buja L.M. The response of neonatal rat ventricular myocytes to lipopolysaccharide-induced stress. Shock May 2006; 25 (5): 546–52.
